New Drug Treats Lung, Thyroid Cancer
This is interesting: https://www.medpagetoday.com/hematologyoncology/lungcancer/86433
"WASHINGTON -- The FDA approved selpercatinib (Retevmo) as the first specific treatment for metastatic non-small cell lung cancer (NSCLC) or thyroid cancer with rearranged during transfection (RET) gene fusions.
This is interesting: https://www.medpagetoday.com/hematologyoncology/lungcancer/86433
"WASHINGTON -- The FDA approved selpercatinib (Retevmo) as the first specific treatment for metastatic non-small cell lung cancer (NSCLC) or thyroid cancer with rearranged during transfection (RET) gene fusions.